UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in Its Charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s Telephone Number, Including Area Code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
Medical Properties Trust, Inc.’s (the “Company”) annual meeting of stockholders was held on May 29, 2025. As of March 18, 2025, the Company’s record date, there were 601,969,612 shares of common stock outstanding and entitled to vote. At the annual meeting, 381,110,311 shares of common stock were represented in person or by proxy and, therefore, a quorum was present. Set forth below are the final voting results for each matter voted upon, including the number of votes that were cast for and against each nominee or proposal, and the number of abstentions and broker non-votes, as applicable. For more information about each proposal, see the Company’s definitive proxy statement, dated April 17, 2025.
Proposal 1: The election of nine directors to the board of directors of the Company, to serve until the next annual meeting of stockholders in 2026 or until their respective successors are elected and qualify:
| Nominee: |
For: | Against: | Abstentions: | Broker Non-Votes: | ||||
| Edward K. Aldag, Jr. |
231,328,734 | 15,474,848 | 5,507,720 | 128,799,009 | ||||
| G. Steven Dawson |
226,218,275 | 20,448,974 | 5,644,053 | 128,799,009 | ||||
| R. Steven Hamner |
232,307,486 | 14,459,798 | 5,544,018 | 128,799,009 | ||||
| Caterina A. Mozingo |
237,063,197 | 9,576,899 | 5,671,206 | 128,799,009 | ||||
| Emily W. Murphy |
236,491,208 | 10,165,029 | 5,655,065 | 128,799,009 | ||||
| Elizabeth N. Pitman |
230,402,552 | 16,247,802 | 5,660,948 | 128,799,009 | ||||
| D. Paul Sparks, Jr. |
233,075,889 | 13,469,149 | 5,766,264 | 128,799,009 | ||||
| Michael G. Stewart |
228,787,254 | 17,737,397 | 5,786,651 | 128,799,009 | ||||
| C. Reynolds Thompson, III |
202,850,473 | 43,675,168 | 5,785,661 | 128,799,009 |
Proposal 2: The ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025:
| For: |
Against: |
Abstentions: |
Broker Non-Votes: | |||
| 370,848,874 | 5,087,420 | 5,174,017 | — |
Proposal 3: The non-binding, advisory vote on named executive officer compensation was approved by the following votes:
| For: |
Against: |
Abstentions: |
Broker Non-Votes: | |||
| 144,439,145 | 103,179,926 | 4,692,231 | 128,799,009 |
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits. |
| Exhibit Number |
Description | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| MEDICAL PROPERTIES TRUST, INC. | ||||||
| Date: June 3, 2025 | By: | /s/ R. Steven Hamner | ||||
| R. Steven Hamner, Executive Vice President and Chief Financial Officer | ||||||